Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
Open Access
- 3 December 2022
- journal article
- review article
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 12 (1) , 81-93
Abstract
Introduction The reactivation of varicella zoster virus (VZV) in previously infected individuals can cause herpes zoster (HZ), which is characterized by a localized, painful dermatomal rash. While there is a global trend of increasing HZ cases, there is a lack of research examining the epidemiology of HZ within the Gulf Cooperation Council (GCC) countries. Therefore, we aimed to critically appraise evidence on VZV and HZ epidemiology in the GCC countries and identify gaps in the current literature. Methods A literature review was conducted via a comprehensive appraisal of the literature. PubMed and local-language journals were searched to identify articles related to HZ and VZV published up until 31 January 2022, with a sole focus on the GCC countries. Included studies reported on surveillance data, seroepidemiology, and patient outcomes for HZ and VZV, and comprised primary data reports, case series, case reports, narrative and systematic literature reviews, studies reporting HZ incidence or prevalence, and Ministry of Health reports. Results Thirteen studies were found that reported on VZV seroprevalence in Saudi Arabia, the United Arab Emirates (UAE), and Qatar, ranging from 15.0% to 92.2%, while no data were identified for Bahrain, Kuwait, or Oman. There was very limited country-wide information on the incidence of HZ in GCC countries, and three identified studies reported HZ prevalence as seen in a single clinic, ranging from 0.62% to 2.3%. A single study from Saudi Arabia and government surveillance data reported on the impact of VZV vaccination on VZV infection, though there was no evidence on the impact of VZV vaccination on HZ. Conclusion There is a clear gap in the literature regarding the incidence of HZ infection, and the impacts of HZ and VZV vaccinations in the GCC countries. Further research into the epidemiology of HZ is necessary to inform the implementation of vaccination programs in the GCC countries. Graphical AbstractKeywords
Funding Information
- GlaxoSmithKline Biologicals SA
This publication has 53 references indexed in Scilit:
- Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical studentsBMC Public Health, 2012
- The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008Epidemiology and Infection, 2011
- Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10‐year survey of 48,388 herpes zoster cases in Miyazaki prefectureJournal of Medical Virology, 2009
- The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster VaccineThe Journal of Infectious Diseases, 2008
- Varicella and Herpes Zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004BMC Infectious Diseases, 2007
- Seroprevalence Survey of Varicella, Measles, Rubella, and Hepatitis A and B Viruses in a Multinational Healthcare Workforce in Saudi Arabia •Infection Control & Hospital Epidemiology, 2006
- Screening Healthcare Workers for Varicella-Zoster Virus: Can We Trust the History?Infection Control & Hospital Epidemiology, 2004
- TORCH Agents in Pregnant Saudi WomenMedical Principles and Practice, 2002
- Early Pregnancy Varicella and Associated Congenital AnomaliesActa Paediatrica, 1989
- Herpes Simplex Virus Type 1 (HSV-1) and Varicellazoster Virus (VZV) Infections in Saudi ArabiaJournal of Tropical Pediatrics, 1989